Option Care Health (NASDAQ:OPCH) Issues Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH - Get Free Report) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the consensus earnings per share estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Wall Street Analyst Weigh In

OPCH has been the topic of several research reports. Jefferies Financial Group lowered shares of Option Care Health from a "buy" rating to a "hold" rating and dropped their price objective for the company from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and cut their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a research report on Monday. JMP Securities restated a "market outperform" rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday. Finally, UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 price objective on the stock. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and a consensus target price of $29.71.

Option Care Health Stock Up 15.5 %

OPCH traded up $3.73 during mid-day trading on Monday, reaching $27.72. 5,926,688 shares of the stock were exchanged, compared to its average volume of 2,114,090. Option Care Health has a 1 year low of $21.39 and a 1 year high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market capitalization of $4.72 billion, a PE ratio of 23.29, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a 50 day moving average price of $23.10 and a two-hundred day moving average price of $27.69.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.64% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.